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Abstract
Background: Subjective visual assessment of cervical cytology is flawed, and this can manifest itself by inter- and intra-
observer variability resulting ultimately in the degree of discordance in the grading categorisation of samples in screening
vs. representative histology. Biospectroscopy methods have been suggested as sensor-based tools that can deliver
objective assessments of cytology. However, studies to date have been apparently flawed by a corresponding lack of
diagnostic efficiency when samples have previously been classed using cytology screening. This raises the question as to
whether categorisation of cervical cytology based on imperfect conventional screening reduces the diagnostic accuracy of
biospectroscopy approaches; are these latter methods more accurate and diagnose underlying disease? The purpose of this
study was to compare the objective accuracy of infrared (IR) spectroscopy of cervical cytology samples using conventional
cytology vs. histology-based categorisation.
Methods: Within a typical clinical setting, a total of n= 322 liquid-based cytology samples were collected immediately
before biopsy. Of these, it was possible to acquire subsequent histology for n= 154. Cytology samples were categorised
according to conventional screening methods and subsequently interrogated employing attenuated total reflection Fourier-
transform IR (ATR-FTIR) spectroscopy. IR spectra were pre-processed and analysed using linear discriminant analysis. Dunn’s
test was applied to identify the differences in spectra. Within the diagnostic categories, histology allowed us to determine
the comparative efficiency of conventional screening vs. biospectroscopy to correctly identify either true atypia or
underlying disease.
Results: Conventional cytology-based screening results in poor sensitivity and specificity. IR spectra derived from cervical
cytology do not appear to discriminate in a diagnostic fashion when categories were based on conventional screening.
Scores plots of IR spectra exhibit marked crossover of spectral points between different cytological categories. Although,
significant differences between spectral bands in different categories are noted, crossover samples point to the potential for
poor specificity and hampers the development of biospectroscopy as a diagnostic tool. However, when histology-based
categories are used to conduct analyses, the scores plot of IR spectra exhibit markedly better segregation.
Conclusions: Histology demonstrates that ATR-FTIR spectroscopy of liquid-based cytology identifies the presence of
underlying atypia or disease missed in conventional cytology screening. This study points to an urgent need for a future
biospectroscopy study where categories are based on such histology. It will allow for the validation of this approach as a
screening tool.
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Introduction
Lack of Sensitivity and Specificity in Cytology-based
Screening
While systematic cervical cancer screening programmes have
been shown to reduce disease burden, there remains concern over
the lack of sensitivity and specificity with conventional cytological
testing. Cytological testing involves collection of exfoliated cells
from the cervix and subjective microscopic examination of these
cells post-staining. The sensitivity of conventional cytology ranges
from 30%–87% [1–4]. Several large meta-analyses indicate that
both the sensitivity and specificity of cervical cytology is lower than
previously estimated [1–3]. The low sensitivity for detection of
atypia or underlying disease is attributable to sampling and/or
laboratory errors but most importantly due to inter-observer error
as a result of the subjective nature of cytological interpretation [5].
In spite of the excellent quality of cytology in England, out of
3,759 cytology slides originally classed as normal in patients who
subsequently had cervical cancer, only 45% were found to be
normal on a review while 11% were inadequate, 21% low-grade
(borderline or mild) and 23% high-grade [6]. This was true even
for the best laboratories with high quality assurance and fully-
trained cytotechnologists. Thus, visual cytology screening has
certain inherent limitations.
Spectroscopy-based Methods as a Novel Screening/
Diagnostic Tool
To overcome diagnostic shortcomings in cervical screening, an
objective test that can detect dysplasia with a higher sensitivity and
also predict irreversible commitment to developing invasive
disease is needed. Newer diagnostic tools to improve accuracy
and reduce subjectivity are emerging with applicability in both
developed and developing countries. Such tools include vibrational
spectroscopy [infrared (IR) or Raman], laser-induced fluorescent
spectroscopy, optical coherence tomography and confocal imag-
ing. Spectroscopy measurements are derived following the
absorption, emission or scattering of electromagnetic radiation
by atoms or molecules. The application of various spectroscopic
methods to study different forms of biological and/or biomedical
material can be termed as biospectroscopy [7]. IR spectroscopy is
based on the vibration of atoms within a molecule. When a
biological sample is interrogated with IR, an absorbance spectrum
is generated which measures the fraction of the incident radiation
that is absorbed at different frequencies by the sample. The
features of an IR spectrum (i.e., number of IR absorption bands,
their intensities and their shapes) are directly related to the
molecular structure of a compound. Due to its ability to provide
information on fundamental structures of biological compounds,
the mid-IR wavenumber region 1,800 cm21 to 900 cm21 is
known as ‘‘biochemical-cell fingerprint’’ region.
Attenuated total reflection Fourier-transform IR (ATR-FTIR)
spectroscopy is a vibrational spectroscopy method that exploits the
ability of cellular biomolecules to absorb in the mid-IR region
(l=2.5–25 mm) through vibrational transitions of chemical bonds
[8,9]. These vibrations include stretching, bending, rocking, and
scissoring movements of the atoms in molecules. It permits the
detection and measurement of cellular biomarkers including DNA,
RNA, lipids, proteins, phosphates and carbohydrates [8,10–12].
The cellular biomolecules that absorb at different wavenumbers
include Amide I (<1,650 cm21), Amide II (<1,550 cm21), protein
(<1,425 cm21), Amide III (<1,260 cm21), asymmetric phosphate
stretching vibrations (nasPO2
2, <1,225 cm21), carbohydrate
(<1,155 cm21), symmetric phosphate stretching vibrations
(nsPO2
2, <1,080 cm21) and protein phosphorylation
(<970 cm21).
Raman spectroscopy can be complimentary to IR due to
differences in the excitation conditions for both the techniques:
change of dipole moment (vector quantity) in the case of an IR
spectrum and change of polarization (tensor quantity) in the case
of a Raman spectrum. In Raman, the excited vibrational state is
directly approached. Raman peaks can collectively provide a
‘biochemical-cell fingerprint’ of the sample, which contains a high
profile spectrum of chemical bonds associated with lipids, DNA,
RNA and proteins [13]. Mahadevan-Jansen and colleagues
reported on the potential use of near-IR Raman spectroscopy to
distinguish cervical cytology grades [14]. They developed a
compact fibre-optic probe to measure the in-vivo Raman spectra
of cervical tissue [15]. Further studies have shown promising
results for application of this method in grading cervical pre-
cancer [16]. In a recent study, confocal Raman spectroscopy
coupled with principal component analysis-linear discriminant
analysis (PCA-LDA) modelling yielded a diagnostic accuracy of
84.1% (a sensitivity of 81.0% and a specificity of 87.1%) for in-vivo
discrimination of dysplastic cervix [17]. Apart from being non-
destructive and non-invasive, the other distinct advantage of
Raman spectroscopy is that it can be used in vivo, and is unaffected
by water. The limitations are its relatively low sensitivity and
undesired fluorescence compared to IR. Relatively expensive and
sophisticated instrumentation also should be taken into account.
The LuViva multimodal hyperspectroscopy (MHS) device has
been investigated as a primary screening tool for moderate and
high-grade cervical cytology. It detects changes in cervical cells by
shining light on the cervix and measuring the patterns of reflected
light. Optical coherence tomography (Niris Imaging System), the
Epitheliometer, and the Dynamic Spectral Imaging System
(DySIS) are other new methods under evaluation, all of which
can be used as an adjunct to colposcopy.
Biospectroscopy as a Novel Screening/Diagnostic Tool
While cytology testing relies on morphological parameters and
staining patterns, biospectroscopy records the spectral information
from cytology reflecting its biochemical composition, including
cells from an interrogated liquid-based cytology (LBC) specimen.
Biospectroscopy approaches with multivariate analyses have
shown potential to detect cell abnormalities at molecular levels,
which occur before the changes in morphology are seen under the
light microscope [8,9,18,19]. Spectra obtained with ATR-FTIR
spectroscopy differ from normal cytology to atypia and invasive
disease [9,18–23]. ATR-FTIR spectroscopy is also capable of
distinguishing between hrHPV infections in women exhibiting
pre-cancerous cervical cellular atypia [24]. In ATR-FTIR
spectroscopy, the signal-to-noise ratio is minimized by setting the
spectral acquisition conditions at 8 cm21 resolution, 2.2 kHz
mirror velocity and 32 co-additions [8]. Pre-processing of spectra
minimizes any interferences caused by instrumentation, sample
preparation, and spectra acquisitions.
Preparation of a cytology sample before obtaining spectra takes
about 30 minutes with current methods of centrifugation; samples
are stored in a desiccator. ATR-FTIR spectroscopy can record 10
spectra from a cytology sample within 15 minutes; this can
undoubtedly be automated and speeded up. In conventional
cytology, the LBC sample is processed to remove any contami-
nants and slides are prepared automatically. The process would
take on an average 15 minutes [8]. On average, a cytotechnologist
would screen 12.5 slides per hour and works for eight hours a day.
However, adequate training of a cytotechnologist takes about 2
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years and a trained pathologist is still required to review any
abnormal cytology and make a final diagnosis [25].
Validation of Biospectroscopy in Clinical Setting:
Subsequent Histology as Gold Standard
While earlier biospectroscopy studies were challenged on
grounds that the segregation between cytological categories could
be due to contaminated samples, more recent studies using LBC
have resolved this issue [18,20,26–29]. Large-scale studies of IR
spectroscopy have emerged in recent years and shown promise for
this technique to be used as a screening or diagnostic tool for
cervical cancer [19,29,30]. However, significant overlap between
various cytology categories had been observed suggesting a lower
accuracy for IR spectroscopy [29,31]. This has led to the
conclusion that biospectroscopy-based categorisation of cervical
cytology is apparently flawed in its ability to detect atypia or
underlying disease. However, previous IR spectroscopy studies
have utilized cytology-based categorisation as a gold standard to
determine the accuracy of biospectroscopy in detection of
cytological atypia or underlying disease. Considering the fact that
cervical cytology-based categorisation has low sensitivity and
specificity as well as poor correlation with subsequent histology,
using cytology as a gold standard to ascertain the accuracy of
biospectroscopy methods is always likely to generate flawed results.
The ideal study to assess the accuracy of biospectroscopy in
detecting atypia or underlying disease in cervical cytology should
be based on comparisons with corresponding histopathological
diagnosis on biopsy, which is considered the gold standard for
diagnosis of cervical dysplasia and invasive carcinoma.
Aims and Objectives
This pragmatic study was carried out in a population
undergoing colposcopy-based cervical screening in accordance to
the European/Greek/UK NHS guidelines with histological
biopsies from a large proportion of participants. Our objective
was to determine whether biospectroscopy appears flawed based
on imperfect conventional cytological screening categorization or
if it can diagnose underlying relevant abnormality based on
histological biopsies taken immediately after index LBC.
Materials and Methods
Participants
Informed written consent to use cervical tissue for research was
obtained from women (i.e., study participants) attending clinics for
cervical cytology screening between October 2009 and August
2012. On the advice of the Acting Director of the University
General Hospital of Ioannina, Institutional Review Board (i.e.,
Ethics Committee) approval was obtained [protocol, 28/9-7-
2009(s.22)]. Similarly, ethics committee approval was obtained
from the local research and ethics committee of Hippokration
Hospital at University of Thessaloniki [approval number 3715/21-
03-2011] for collection of samples at the Second Department of
Obstetrics and Gynaecology, Hippokration Hospital, University of
Thessaloniki, Greece. Relevant consent documentation was
securely archived in said departments with each patient identifier
coded so as to retain the anonymity of study participants. A total of
n=350 LBC samples were collected with RoversTM Cervex-brush
in a ThinPrep solution (PreservCyt; Cytyc, USA) from n=281
patients.
Liquid-based Cytology (LBC) Samples
LBC was repeated immediately before colposcopy assessment
and this was the index cytology and not the initial primary
screening smear, which might have been assessed in several
different laboratories. Each cytology sample underwent cytopatho-
logical examination by the resident qualified cytopathologists in
two respective university hospitals within quality-assured labora-
tories. Cervical cytology is graded semi-quantitatively depending
on the cellular morphology into Negative, atypical squamous cells
of undetermined significance (ASCUS), low-grade squamous
intraepithelial lesion (LSIL), high-grade squamous intraepithelial
lesion (HSIL) and cancer. Specimens exhibiting viral changes
without atypia were classed as HPV or koilocytosis. The
corresponding Bethesda grades [32] for cytological abnormalities
are as follows: ASCUS and HPV-like feature (borderline nuclear
abnormality - BNA); LSIL (mild dyskaryosis); and, HSIL
(moderate and severe dyskaryosis). Out of the total number of
cytology specimens, n=120 were categorised as Negative, n=88
LSIL, n=50 HSIL, n=50 ASCUS, n=12 HPV, and n=2 cancer.
Patients who had unsatisfactory cytology, glandular abnormalities,
and those with previous laser treatment, large loop excision of
transformation zone (LLETZ), cryotherapy, or other cervical
procedures within the previous six months were excluded (n=28).
Histology Samples
Patients were managed according to standard protocols in line
with European/Greek/UK guidelines. As this was a pragmatic
study, colposcopists decided whether to take representative
biopsies according to referral smear results, patient characteristics
and colposcopic findings. Biopsies were either punch or excisional
biopsies. None of these guidelines recommend biopsies after low-
grade cytology and negative adequate colposcopy as the only way
of minimizing verification bias is by performing loop excision of
the transformation, which is associated with long-term fertility
morbidity. The histopathological categories for squamous intra-
epithelial lesion (SIL) are divided into different grades of cervical
intraepithelial neoplasia (CIN). Low-grade lesions with less risk of
disease development and higher chance of regression are
categorised as CIN1 and correspond to LSIL in cytology, while
high-grade lesions such as CIN2/CIN3 (also known as CIN2+)
exhibit an increased risk of commitment to invasive disease and
correspond to HSIL in cytology. The availability of a large
proportion of representative follow-up histology for abnormal
cytology is the major strength of the longitudinal study, and an
overriding weakness of previous spectroscopic studies. Represen-
tative cervical tissue for subsequent histology was obtained from
almost all the HSIL (48 out of 50; 96%) and the majority of LSIL
(60 out of 88; 68%). Biopsy samples were also obtained from a
representative proportion of the Negative cytology cohort (19 out
of 120; 16%), ASCUS (17 out of 50; 34%) and HPV-like features
(8 out of 12; 67%). Fig. 1 shows the flow diagram of cervical
cytology classes and follow-up histology results; Table 1 shows the
correlation of cytology with subsequent histology. Out of all
subsequent histology samples to assess the accuracy of biospectro-
scopy, n=41 were normal, n=57 CIN1, n=44 CIN2+, and n=12
cancer.
Sample Preparation for ATR-FTIR Spectroscopy
An aliquot of 6 ml of cytology specimen in ThinPrep solution
was centrifuged at 1500 rpm for 5 min, after which the
supernatant (i.e., methanol fixative in ThinPrep) was then
aspirated (Fig. 2). Remaining cell pellet was re-suspended in
3 ml autoclaved distilled H2O and centrifuged at 1,500 rpm for
5 min, and the supernatant was again removed [8,9]. This wash
step was repeated three times and, the resulting cell pellet was then
re-suspended in 0.5 ml autoclaved distilled H2O and transferred
onto a low-E glass microscope slide (Kevley Technologies,
Biospectroscopy of Liquid-Based Cervical Cytology
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Chesterland, OH, USA). Slides were allowed to air-dry and stored
in a desiccator until analysis, thereby removing the possibility of
water contributing to the spectral signature.
Sample Thickness
When transferring the cellular material to a slide, we ensured an
even deposition. In ATR-FTIR spectroscopy, an IR evanescent
wave penetrates only a few mm into the sample. Samples can
Figure 1. Flow diagram depicting the results of initial cervical cytology (n=322) and subsequent histology (n=154) of liquid-based
cytology (LBC) samples. The cytology categories include negative, low-grade squamous intraepithelial lesion (LSIL), high-grade intraepithelial
lesion (HSIL), atypical squamous cells of unknown significance (ASCUS), koilocytosis or HPV and cancer. The histological categories include normal,
cervical intraepithelial neoplasia grade 1 (CIN1), cervical intraepithelial neoplasia grade 2+ (CIN2+) and cancer.
doi:10.1371/journal.pone.0082416.g001
Table 1. Correlation of cytology with subsequent histology.
Cytology* Histology* (n=154)
Normal (n=41) CIN1 (n=57) CIN2+ (n=44) Cancer (n=12)
Normal (n= 19) 10 (53%) 5 (26%) 4 (21%) 0
LSIL (n=60) 21 (35%) 33 (55%) 5 (8%) 1 (2%)
Koilocytosis or HPV (n=8) 2 (25%) 5 (62%) 1 (13%) 0
HSIL (n= 48) 3 (6%) 5 (10%) 31 (65%) 9 (19%)
Cancer (n= 2) 0 0 0 2 (100%)
ASCUS (n= 17) 5 (30%) 9 (53%) 3 (17%) 0
*Abbreviations: ASCUS, atypical squamous cells of unknown significance, HSIL, high-grade squamous intraepithelial lesion, LSIL, low-grade squamous intraepithelial
lesion, CIN, cervical intraepithelial neoplasia, HPV, human papilloma virus.
doi:10.1371/journal.pone.0082416.t001
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therefore be quite thick, with a minimum thickness of 3–5 mm.
Too-sparse or too-thin samples will produce spectra of low signal-
to-noise ratio. In our studies, we have observed that small areas of
thick sample are most appropriate for ATR-FTIR spectroscopy. In
addition, we ensured that the sample thickness did not influence
the results of the spectra by allowing the Amide I peak of acquired
spectra to reach beyond 0.12 a.u. (arbitrary units). This is achieved
by adjusting the amount of pressure applied to the region of
interest.
Biospectroscopy: Instrumentation and Parameters
Spectroscopic interrogation of cytology samples was performed
with ATR-FTIR spectroscopy at the Centre for Biophotonics
(Lancaster University, UK). Cytological and histological diagnoses
were unknown to those who performed IR spectroscopy. IR
spectra were obtained using a Bruker TENSOR 27 FTIR
spectrometer with Helios ATR attachment containing a diamond
crystal (Bruker Optics Ltd, Coventry, UK) and operated using
OPUS 6.5 software (Bruker Optik GmbH). Using a CCTV
camera, spectra were acquired from 10 independent sample
locations. The following data acquisition parameters were used:
8 cm21 spectral resolution giving 4 cm21 data spacing, 32 scans,
6 mm aperture setting and 26 Zerofilling factor. The ATR
diamond crystal was washed with distilled water and, dried with
tissue paper between each sample and before each new slide. A
background absorption spectrum (for atmospheric correction) was
taken prior to each new sample.
Spectral Pre-processing
Spectra were converted into absorbance by Bruker OPUS
software. The datasets were pre-processed using MATLAB
R2010a software (Mathworks Inc, Natick, MA, USA) with the
IRootLab toolbox (http://irootlab.googlecode.com; Fig. 3A–3E)
[8,33]. IR spectra were pre-processed in three steps, which include
cutting, baseline correction and normalization. This approach is
most efficient in maintaining the integrity of the original spectra
[8]. Spectra were pre-processed to account and correct for noise,
sloping baseline effects, differences in sample thickness/concen-
Figure 2. Flow diagram of sample collection, sample preparation, spectroscopy, pre-processing of spectra and feature extraction.
After sampling of the transformation zone (TZ), the cells are suspended in ThinPrep solution. An aliquot of 6 ml of cytology specimen was centrifuged
at 1,500 rpm for 5 min, after which the supernatant was then aspirated. The remaining cell pellet was re-suspended in 3 ml autoclaved distilled H2O
and centrifuged at 1500 rpm for 5 min, and the supernatant was again removed. This wash step was repeated three times and, the resulting cell
pellet was then re-suspended in 0.5 ml autoclaved distilled H2O and transferred to a low-E glass microscope slide. Slides were allowed to air-dry and
stored in a desiccator until analysis. Infrared (IR) spectra were obtained using a Bruker TENSOR 27 FTIR spectrometer with Helios ATR attachment
containing a diamond crystal. Using a CCTV camera, spectra were acquired from 10 independent sample locations. The datasets were processed
using MATLAB R2010a software (Mathworks Inc, Natick, MA, USA) with the IRootLab toolbox (http://irootlab.googlecode.com). IR spectra were pre-
processed in three steps, which include cutting, baseline correction and normalization. Feature extraction was carried out using linear discriminant
analysis, which allowed for segregation of classes and peak detection plots allowed identification of biomarkers.
doi:10.1371/journal.pone.0082416.g002
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tration, and to select the regions of interest. In cutting, the spectra
are cut between the regions of interest, such as the biochemical-cell
fingerprint regions (1,800 cm21–900 cm21), typically containing
235 variables (i.e., 235 wavenumbers at 3.84 cm21 spectral
resolution). Baseline correction methods such as ‘‘rubberband’’
aims to correct sloped or oscillatory baselines that arise as a result
of physical phenomena such as IR dispersion caused by Mie
scattering [34]. Normalization aims to correct for differences in
absorbance intensities across spectra that result from variable
sample thickness or concentration. Normalization was done by
scaling spectra to the highest peak (i.e., Amide I).
Multivariate Analysis
The data processing is directed towards visualising data as
graphs, which allows one to gain insights into underlying biological
alterations [35]. Multivariate analysis was performed with LDA
using MATLAB (http://www.mathworks.com) with the IRootLab
toolbox (http://irootlab.googlecode.com) [8,33]. Scores plots are
used for the visual representation and interpretation of the
variables responsible for separation of spectral categories as the
Cartesian coordinates after application of linear methods such as
principal component analysis (PCA), linear discriminant analysis
(LDA) or PCA-LDA. As the numbers of spectra in the cytology
dataset (3,220 spectra) are more than five times the numbers of
variables (235 data points), we applied LDA as a linear method of
spectral analysis [7,35,36]. LDA is a supervised technique, which
forms linear combinations of variables dependent on differences
between the categories in the dataset. It minimises within-category
differences (which would mostly be associated with typical
heterogeneity) while maximizing between-category discriminating
characteristics (i.e., those most likely to be diagnostic).
LDA reduces the numbers of variables within spectral data from
235 to a few (2–7 LDs depending on number of classes). Using
linear discriminant 1 and 2 (LD1 and LD2), which represent
almost 99% of data, scores plots were obtained for various
cytological categories. This pattern-finding LDA approach is to
identify how different cytology categories relate to each other (e.g.,
which categories are closely clustered or distant from each other)
and thereby allows one to understand the underlying biochemical
alterations responsible for separation of cytology grades. The
ellipse around each class represents a 90% confidence interval
region. This confidence ellipse or confidence region is used to
indicate the reliability of the spectral category means. The level of
confidence indicates the probability with which the confidence
region captures the ‘‘true’’ (unknown) category mean [37].
Considering cytology as an imperfect tool, IR spectra were
subsequently categorised based on subsequent histology and LDA
carried out on the histological classes.
Along with the scores plots, the linear method of feature
extraction also identifies the contribution of each wavenumber-
variable responsible for generating the factors known as loading
vectors. A cluster vector approach produces a set of biomarkers
per data category [38–40]. To obtain a peak detection plot, a
cluster vector is drawn from the centre of a reference category (i.e.,
the ‘‘Negative or Normal cytology’’ group) to the centre of an
abnormal cytology cluster in the vector space spanned by the LDA
loadings vectors. Subsequently, a peak detection algorithm is
applied to identify the six most prominent peaks from each cluster
vector and plotted locations of detected peaks along wavenumber
line using marker symbols. Size of marker symbol is proportional
to the height of their corresponding peak [10]. Absolute values
were used to measure the height of the peaks from cluster vector
plots in order include both the negative and positive values. Thus,
the peak detection plots show the wavenumbers that are
responsible for the differences amongst the categories. All
wavenumbers are rounded down to the nearest whole number.
Statistical significance of each linear discriminant (LD) contrib-
uting to inter-category segregation for cytology/histology correla-
tion of normal and high grade histology was determined by the
Dunn’s multiple comparison test (Prism 5, GraphPad Software
Inc., La Jolla, CA, USA). Dunn’s test compares the difference in
the sum of ranks between two columns with the expected average
difference (based on the number of groups and their size). The
performance of two algorithms is significantly different if the
corresponding average of rankings is at least as great as its critical
difference. It is also referred to as post-test following a Kruskal-
Wallis test [41,42].
Results
Linear Discriminant Analysis (LDA) of IR Spectra Based on
Conventional Screening
The variations of IR spectra for Negative (n=120), LSIL
(n=88) and HSIL (n=50) were examined. Significant overlap was
observed in the LDA-derived scores plots for all three grades with
only minimal evidence of segregation between categories (Fig. 4A).
The overlap region was smaller for Negative vs. HSIL (Fig. 4B)
and LSIL vs. HSIL (Fig. 4C) as compared to Negative vs. LSIL
(Fig. 4D). Fig. 4E shows the top six peak assignments responsible
for segregation IR spectra of Negative from LSIL and HSIL.
Apart from the aforementioned three categories (i.e., Negative,
LSIL and HSIL), the IR spectra of ASCUS (n=50), HPV-like
features (n=12) and cancer (n=2) were also studied. Fig. 5A shows
the 2-D scores plot after LDA of the IR spectra from all six
cytological grades exploiting the similarities and differences in
their biomolecular alterations as revealed by overlap and
separation of spectral points. While the spectral points of cancer
on cytology clustered remarkably in close proximity to HSIL
(Fig. 5B), the IR spectra of ASCUS showed a distribution of points
across all three categories with no specific pattern (Fig. 5C). The
HPV-like features on cytology (Fig. 5D) were mostly clustered
close to LSIL with some distribution near the Negative cytology.
Fig. 5E shows the peak detection plot with the top six
wavenumbers that resulted in segregation of Negative from
HPV, ASCUS and Cancer spectra.
It is known that the histopathological diagnosis of given grades
of CIN has poor reproducibility [43,44]. Despite this, the
separation of CIN into three subcategories (e.g., CIN1, CIN2
and CIN3) correlates to a general extent with rates of development
and regression of the intraepithelial lesion [45]. Histology is
considered the gold standard for diagnosis of underlying pre-
invasive disease in cervical screening. Out of all histology
specimens (n=154), nineteen were associated with Negative
cytology. The correlation of Negative cytology with concurrent
histology was poor with only about half of the patients with
Negative cytology showing no histopathological abnormality.
Thus, the false negative rate was very high with about 47% of
the Negative cytology having CIN on histology. Out of n=40
Figure 3. Pre-processing of infrared (IR) spectra obtained from cervical cytology specimens. (A) All spectra in the mid-IR region; (B)
Spectra cut between 1,800 cm21 to 900 cm21; (C) Rubberband-like baseline correction; (D) Normalization to Amide I peak; and, (E) Spectra of n= 322
cytology specimens (28 unsatisfactory specimens removed) classed by cytology and histology.
doi:10.1371/journal.pone.0082416.g003
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Figure 4. Comparison of infrared (IR) spectra from LBC samples using LDA scores plot with confidence ellipse representing
confidence interval at 90% for the observed values. (A) Negative vs. LSIL vs. HSIL; (B) Negative vs. HSIL; (C) LSIL vs. HSIL; and, (D) Negative vs.
LSIL; (E) Corresponding peak detection plot with top six wavenumbers responsible for segregation of Negative from LSIL and HSIL.
doi:10.1371/journal.pone.0082416.g004
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patients with HSIL, 65% (31/48) had high-grade CIN, 19% (9/
48) had cancer, 10% (5/48) had CIN1 and 6% (3/48) had normal
histology. When patients (n=68) with low-grade cytology (LSIL/
HPV-like features) were classed on subsequent histology; 56% had
CIN1, 9% had high-grade CIN, one had cancer and 34% had
normal histology. When ASCUS cytology was determined by
Figure 5. Comparing various cytology grade spectra using multivariate analysis. (A) Comparison of spectral points for Negative vs. LSIL vs.
HSIL (closed symbols) with HPV vs. ASCUS vs. Cancer (open symbols). Scores plots with confidence ellipse showing the relationship of (B) cancer with
HSIL; (C) ASCUS with LSIL; and, (D) HPV-like features with Negative cytology; (E) Peak detection plot following linear discriminant analysis (LDA)
showing top six wavenumbers responsible for segregation of Negative cytology from ASCUS, HPV and Cancer cytology.
doi:10.1371/journal.pone.0082416.g005
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follow-up histology, about half were CIN1 (9/17), 30% (5/17)
were normal and 17% (3/17) had high-grade CIN. In ASCUS, the
cytology displays cellular abnormalities more marked than simple
reactive changes (atypical squamous cells), but does not meet
criteria for squamous intraepithelial neoplasia. Thus, ASCUS is
likely to represent the normal or low-grade cytological change;
however, the potential to have high-grade disease within this
category exists.
Categorisation of IR Spectra Based on Gold Standard
Subsequent Histology
In this analysis, the IR spectra of LBC specimens with
subsequent follow-up histology results available (n=154) were
analysed according to cytological and histological categories.
Fig. 6A shows a 2-D scores plot after LDA of IR spectra from
Negative, LSIL and HSIL cytology as categorised by the cytology
and Fig. 6B shows a 2-D scores plot of IR spectra of cytology as
classed by corresponding subsequent histology. Fig. 6C and 6D
shows the 2-D scores plots with confidence ellipses and double-
coloured spectra. The IR spectral points with agreement between
cytology and subsequent histology are within the confidence ellipse
while the spectral points for the discordant grades of cytology are
depicted as double-coloured symbols.
When IR spectra are analysed using cytology grades (Fig. 6A),
poor correlation of spectral points with histology is observed
(Fig. 6C). This is because the cytology-based grading ignores the
discrepancy (discordance) between the cytology and histology. In
other words, this can be regarded as a teaching error. The
observed overlap of spectral points suggests that perhaps
biospectroscopy-based classification of spectral cytology is not
very robust. However, when the IR spectra of cytology are graded
according to histology (Fig. 6B), the correlation of spectral points
with histology is highly accurate (Fig. 6D). The histology-based
grading of IR spectra derived from cytology samples are depicted
by double-coloured scores in Fig. 6D and explains the overlap
regions seen in Fig. 6B. Thus, multivariate analysis of the cytology-
derived IR spectra using histology results in accurate assignment of
categories irrespective of discordant cytology (see the double-
coloured scores plots in Fig. 6C and 6D).
Negative screening and high-grade intraepithelial lesions are the
two most common results that influence the risk of developing
cervical cancer and therefore the treatment choice. While no
intervention would be required in Negative cytology, high-grade
lesions require abnormal cells to be removed with surgical
intervention. The IR spectra from these two cytological categories
were further characterised for accuracy of identification of
corresponding histological category.
The IR spectra of patients with normal histology but differing
cytology grades were plotted in relation to the confidence ellipse
for histological categories (Fig. 7A). Despite the differing grades of
Figure 6. Analysis of infrared (IR) spectra from cervical cytology samples with subsequent histology (n=154). LD1 and LD2 were
used to plot the confidence ellipses for cancer (violet), high-grade lesion (red), low-grade lesion (blue) and Negative (green). (A)
Comparison of linear discriminant analysis (LDA) scores plots of IR spectra according to conventional cytology grades: Negative vs. LSIL vs. HSIL; (B)
Comparison of LDA scores plots according to subsequent histology grades: Normal vs. CIN1 vs. CIN2+ vs. Cancer. In the next two figures, the scores
plot for discordant cytology and histology were depicted by double-coloured symbols, with the outer colour determining the cytology grade and the
inner colour determining the histology grade; (C) Comparison of LDA scores plots derived from IR spectra analysed using cytology-based categories;
and, (D) Comparison of LDA scores plots derived from IR spectra analysed using subsequent histology-based categories.
doi:10.1371/journal.pone.0082416.g006
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cytological atypia as determined by imperfect cytological screen-
ing, the IR spectral points for normal histology were seen
clustering within the ellipse of normal histology in a 2-D scores
plot. The spectra for HPV with normal follow-up histology were
seen in the overlap region of normal and low-grade histology.
Furthermore, when spectral points for Negative cytology were
projected as LDA scores plots according to the subsequent
histology (Fig. 7B), clear differences are observed (Table 2)
between normal vs. CIN1 (P,0.001) and CIN2+ vs. CIN1
(P,0.001). The CIN2+ vs. Normal spectral categories exhibit
good segregation (P,0.05) with some overlap, possibly due to the
limited number of specimens within the Negative cytology
category (n=10).
The cytological spectra of LBC specimens with histology
suggestive of CIN2+ and cancer were analysed in relation to the
initial screening cytology. A remarkable degree of agreement was
observed in the spectral points of IR spectra for high-grade lesions
on histology, irrespective of the varying degree of discordance in
initial cytology (Fig. 8A). The spectral points of Negative cytology
but high-grade histology are seen in HSIL ellipse. As seen in
Fig. 8A, ASCUS with CIN2+ histology clustered within the high-
grade lesion ellipse. The spectral points for CIN2+ in HPV
cytology clustered in the overlap region between all three
categories but more towards the high-grade ellipse (Fig. 8A).
When spectra for HSIL were classed on LDA using histology
(Fig. 8B), excellent separation of normal from all other grades was
observed (Table 3). It is worth mentioning that the cancer category
for cytology and histology are of a limited sample size (n=12 and
2, respectively), which is likely to influence the analysis.
One of the major advantages of biospectroscopy over other
analytical methods is the ability to identify most important
discriminating wavenumber-variables to lend further insights into
biological mechanisms. The responsible wavenumbers with their
biochemical assignments for segregation of Negative cytology from
Figure 7. Infrared (IR) spectral points of cytology in relation to normal histology. (A) IR spectra for normal histology classified according to
the screening cytology results and in relation to the confidence ellipses of histology grades; and, (B) Analysis of IR spectra from normal cytology
classified according to subsequent histology.
doi:10.1371/journal.pone.0082416.g007
Table 2. Spectral variations amongst histology of Negative cytology.
Dunn’s Multiple Comparison Test Difference in rank sum P-value Summary
CIN2+ vs. Normal 229.47 P,0.05 *
CIN2+ vs. CIN1 2114.9 P,0.001 ***
Normal vs. CIN1 285.44 P,0.001 ***
doi:10.1371/journal.pone.0082416.t002
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LSIL were mostly attributed to DNA/RNA nasPO2
2
(1,200 cm21) and COO- symmetric stretching vibrations of fatty
acids and amino acid (1,408 cm21) (Fig. 4E; Table 4). Similar
wavenumber contributions have been reported for inter-category
variance between Negative vs. LSIL [9,19]. The wavenumbers
segregating Negative from HSIL are assigned to protein
phosphorylation (988 cm21) and glycogen (1,042 cm21) alter-
ations; in contrast, LSIL vs. HSIL were segregated due to
alterations in proteins (1,481 cm21) and protein phosphorylation
(988 cm21). Glycogen, which is abundant in normal squamous
epithelial cells of the cervix, contributes significantly to the
segregation of normal cells from high-grade lesions. However,
the increasing grades of squamous neoplasia from LSIL to HSIL
result in alterations mainly in intracellular proteins and membrane
proteins/lipids. The important wavenumber assignments for
Negative vs. HPV were mainly attributed to Amide III
(1,246 cm21) and protein vibrations (1,439 cm21) while those for
Negative vs. ASCUS were due to protein phosphorylation
(930 cm21) and Amide III (1,254 cm21). The wavenumber
assignments separating Negative from cancer were nsPO2
2
(1,072 cm21) and COO- symmetric stretching vibrations of fatty
acids and amino acid (1,358 cm21) (Fig. 5E; Table 5).
Discussion
The objective of cervical cancer screening programmes is to
reduce the incidence and mortality from this disease by identifying
Figure 8. Infrared (IR) spectral points of cytology in relation to high-grade histology. (A) IR spectra for high-grade histology (CIN2+ and
cancer) classified according to the screening cytology result and in relation to the confidence ellipses of histology grades; and, (B) Analysis of IR
spectra of high-grade lesions cytology classified according to subsequent histology.
doi:10.1371/journal.pone.0082416.g008
Table 3. Spectral variations amongst histology of HSIL cytology.
Dunn’s Multiple Comparison Test Difference in rank sum P-value Summary
CIN1 vs. CIN2+ 2156.2 P,0.001 ***
CIN1 vs. Normal 107.8 P,0.01 **
CIN1 vs. Cancer 2123 P,0.001 ***
CIN2+ vs. Normal 264 P,0.001 ***
CIN2+ vs. Cancer 33.18 P.0.05 ns*
Normal vs. Cancer 2230.8 P,0.001 ***
*Abbreviation: ns, not significant.
doi:10.1371/journal.pone.0082416.t003
Biospectroscopy of Liquid-Based Cervical Cytology
PLOS ONE | www.plosone.org 12 January 2014 | Volume 9 | Issue 1 | e82416
women with pre-cancerous cervical lesions and early invasive
cancers, and treating these individuals appropriately. Establishing
national cervical cancer screening programmes in developing
countries has failed as a result of the complexity of the
infrastructure required and the intensity of competing health
needs [23]. Part of the problem in running a successful programme
is the poor sensitivity and a poor positive predictive value of
cervical cytology [4,46,47]. High-risk HPV-DNA testing has
higher sensitivity but lower specificity than cytology [48]. Visual
inspection with acetic acid (VIA) is a low-cost, point-of-care test
but suffers from a poor positive predictive value with the risk of
significant over-treatment [49]. The search for newer low-cost
Table 4. Top six wavenumbers responsible for separating negative, LSIL and HSIL.
Comparisons Wavenumbers Tentative assignments
Negative vs. HSIL 988 cm21 Protein phosphorylation
1042 cm21 Glycogen
1204 cm21 C-O, C-N, C-C bonds
1238 cm21 Asymmetric phosphate stretching vibrations (nasPO2
2)
1292 cm21 Amide III
1408 cm21 COO- symmetric stretching vibrations of fatty acids and amino acid
Negative vs. LSIL 1200 cm21 C-O, C-N, C-C bonds of DNA/RNA nasPO2
2
1265 cm21 Amide III
1408 cm21 COO- symmetric stretching vibrations of fatty acids and amino acid
1481 cm21 Proteins?
1612 cm21 Amide I
1755 cm21 Lipids
LSIL vs. HSIL 988 cm21 Protein phosphorylation
1188 cm21 Carbohydrate
1292 cm21 Amide III
1481 cm21 Proteins
1620 cm21 Amide I
1755 cm21 Lipids
doi:10.1371/journal.pone.0082416.t004
Table 5. Top six wavenumbers responsible for separating negative cytology from HPV, ASCUS and Cancer.
Comparisons Wavenumbers Tentative assignments
Negative Vs HPV 1246 cm21 Amide III
1296 cm21 Amide III
1335 cm21 COO- symmetric stretching vibrations of fatty acids and amino acid
1400 cm21 COO- symmetric stretching vibrations of fatty acids and amino acid
1439 cm21 Proteins
1582 cm21 Amide II
Negative Vs ASCUS 930 cm21 Protein phosphorylation
1072 cm21 Symmetric phosphate stretching vibrations (nsPO2
2)
1254 cm21 Amide III
1358 cm21 COO- symmetric stretching vibrations of fatty acids and amino acid
1447 cm21 Proteins?
1609 cm21 Amide I
Negative Vs Cancer 980 cm21 Protein phosphorylation
1072 cm21 nsPO2
2
1134 cm21 C-O stretch (nu CO)
1250 cm21 Amide III
1358 cm21 COO- symmetric stretching vibrations of fatty acids and amino acid
1609 cm21 Amide I
doi:10.1371/journal.pone.0082416.t005
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technologies in cervical cancer screening thus continues. To use
inexpensive technology such as biospectroscopy as a novel
screening tool requires thorough evaluation and assessment. A
part of the process of technology assessment for a novel diagnostic
tool is to identify the appropriate gold standard.
Previous studies determining accuracy of biospectroscopy have
used cytology as a gold standard. When an imperfect gold
standard is used to determine disease status, significant bias can be
introduced into measures of a test’s performance. Histology should
be used as a gold standard to determine the accuracy of a new
screening test for pre-invasive cervical disease.
The accuracy of biospectroscopy of LBC samples as a novel
screening test was compared with conventional cytology screening
using histology as a gold standard. While, conventional cytology
showed a very poor correlation with histology, IR spectra from
LBC specimens showed a more robust segregation of categories
when subsequent histology was used as a gold standard for
analysis. Additionally, the IR spectra of ASCUS and HPV-like
features on cytology appeared to segregate according to their
subsequent histology grades. Thus, biospectroscopy identifies
underlying pre-invasive cervical disease more accurately than
conventional cytology when their performance is determined by
subsequent histology.
Over the last two decades, many researchers across the globe
have applied FTIR spectroscopy to detect pre-invasive disease in
cervical cytology [8,9,18,22,28]. Studies employing multivariate
classification analysis have shown good segregation of cytology
grades [18]. However, most studies determine IR spectroscopy to
be an imperfect tool for assessment of cervical cytology [11,28]. A
recent study was unable to show a significant improvement in class
segregation of cytology grades despite using a large number of
LBC specimens to assess the accuracy of IR spectroscopy [29].
Clearly, the inherent weakness within these studies was the use of
cervical cytology (an imperfect gold standard) grades to compare
the performance accuracy of IR spectroscopy with multivariate
analysis.
In the current study, we prospectively collected histology from
patients undergoing cervical cytology and used it as a gold
standard for the analysis of IR spectra from cytology specimens.
Initial multivariate analysis of IR spectra using cytological
categories showed imperfect categorisation with significant overlap
based on conventional cytology screening grades (Figs. 4 and 5).
However, when IR spectra were classed using subsequent
histology, the spectral points showed discrimination of cytology
grades in accordance with the pattern of underlying disease (Fig. 6).
IR spectra from cytological categories at the beginning and the
end of the disease spectrum (Negative and HSIL) were further
scrutinised based on histology (Figs. 7 and 8). These analyses
explained the segregation of scores plots in the overlap region
(Figs. 7B and 8B).
When IR spectra were categorised by histology grades, high-
grade lesions (CIN2+ and cancer) segregated from normal and
low-grade lesions. However, clear overlap in the spectral points of
low-grade lesion and normal is observed (Fig. 6B & D).
Interestingly, when classed by histology (Fig. 6D), the spectral
points of IR spectra in the overlap region were of the discordant
cytology category (cytology not in agreement with histology).
Thus, biospectroscopy of cytology spectra appears imperfect due
to the discordance between cytology and histology. Histology
reflects the actual underlying disease status. Therefore, the
accuracy of IR spectra of cytology is best scrutinized based on
the histological categories.
The IR spectral-discordant categories for Negative and HSIL
cytology were further characterized based on dual categorisation
with cytology and histology. In conventional cytology, 47% of the
Negative cytology had CIN1 and about 10% of LSIL had CIN2+/
cancer on histology. Thus, cytological screening fails to detect the
true underlying disease in a proportion of LBC specimens resulting
into a significant under-grading of abnormalities. When biospec-
troscopy analysis was applied to these LBC specimens, the spectral
points for discordant grades (Negative cytology but CIN on
histology) of IR spectra showed excellent segregation (Fig. 7B;
Table 2). A retrospective review suggested that a high proportion
of Negative cytology taken up to three and half years before
diagnosis of cancer had abnormal cells [6]. Biospectroscopy has
the potential to identify these ‘‘missing’’ abnormal cells in the
apparently Negative cytology specimen.
Identification of benign lesions (normal) in high-grade cytology
has a potential to prevent unnecessary surgical excision biopsies or
repeat cytology testing. Out of 48 patients with HSIL, 16% were
normal or CIN 1 on histology. The IR spectra of LBC specimens
with normal histology segregated extremely well from low-grade
and high-grade lesions (Fig. 8B). Additionally, biospectroscopy was
able to segregate the IR spectra of ASCUS, low-grade and HPV
diagnosis in cytology but with a high-grade histology. ASCUS with
high-grade histology (ASCUS/CIN2+) could reflect atypical
squamous cells: high-grade (ASC-H), which carries a higher risk
of progression to high-grade lesion and if it remains undiagnosed
may lead to the development of cervical cancer. Biospectroscopy
may identify ASC-H with high likelihood of disease progression
amongst the ASCUS cytology.
This study has some limitations. We did not have histology for
all cytological categories. Therefore, a possibility of selection bias
towards high-grade lesions cannot be ruled out. We have used
histology as a gold standard while the possibility of inter-observer
variability in histological classification of low-grade lesions cannot
also be completely eliminated. The only way to minimize this
verification bias is to perform a LLETZ cervical procedure, which
provides a sample for histological verification. However, in women
with low-grade cytological abnormalities and negative colposcopy,
the consensus view is that this is unethical as the short and long-
term sequalae of LLETZ outweigh the minimal risk of high-grade
disease being present. Despite these limitations, it is clear from the
current study that biospectroscopy has the potential to identify
underlying cervical atypia or invasive disease. Use of cytology-
based categorisation of IR spectra leads to poor assignment of
categories resulting into significant overlap in spectral points.
When histopathological categories are used to carry out multivar-
iate analysis, biospectroscopy is able to determine the atypia or
invasive disease more accurately. Within histology-based catego-
ries, some overlap was observed between classes although the
segregation was better than cytological-based categorisation.
Although, histological diagnosis is considered gold standard, its
limitations are well documented [6,43,50]. Similar to cytology,
histological diagnosis is dependent on interpretation by one or
more pathologists and is subjected to inter-observer variability.
Another possibility is that the biopsy is obtained from an area not
affected by SIL on the cervix. A US-based multicentre trial has
shown that the histopathologic interpretation of excision or a
punch biopsy can be extremely variable, even between the
pathologists at academic medical institutions [50]. Only 43% of
low-grade dysplasia interpretations were reproducible while 90%
of normal and 76% of high-grade dysplasia results showed an
agreement [50]. Thus, one of the inherent difficulties in assessing
the accuracy of any new technology is a comparison with a flawed
gold standard.
Overall, the underlying pre-invasive cervical disease is accu-
rately identified with biospectroscopy when the histology rather
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than conventional screening grades are used as gold standard.
Future studies should exercise caution in interpreting and
concluding results that are just based on imperfect cytology grades
without histology. It is unknown whether the crossover in
histological class is a consequence of imperfect histology or
evidence of the multi-stage process of transformation towards
disease development. To identify this, sequential samples are
required over a period of time from the same patient. Biospectro-
scopy is an inexpensive, automatable tool based on objective
spectral criteria that does not require highly-skilled personnel. It
caries a potential to either be a screening tool in cervical cytology
or can be used as an adjunct to identify discordant cytology in
conventional screening, thus eliminating unnecessary referrals and
treatments and subsequently reducing anxiety and long-term post-
treatment obstetric sequelae [51–54]. It is possible to use
spectroscopy as an adjunct to cytology applying it to identify the
correct categories for false positive and false negative cytology.
Such an approach would allow for resolution of cytology-histology
discrepancies. The cytology laboratory will have centrifuge
therefore the only additional cost would include an ATR-FTIR
spectrometer; this is not envisaged as a major obstacle. Future
studies should be caution in interpreting and concluding results
just based just on imperfect cytology grades without histology.
Acknowledgments
We greatly acknowledge support from Lancashire Teaching Hospitals
NHS Foundation Trust, UK and University Hospital of Ioannina, Aristotle
University of Thessaloniki - Hippokration Hospital and Attikon’’ Hospital,
University of Athens, Greece.
Author Contributions
Conceived and designed the experiments: KG GV CF EP PLM FLM.
Performed the experiments: KG AAA GV CF MN AL MK SMS PK EP
BD. Analyzed the data: KG AAA JT GV CF MN AL MK SMS FLM.
Contributed reagents/materials/analysis tools: GV JT CF MN AL MK
SMS PK EP BD PLM FLM. Wrote the paper: KG AAA GV JT CF MN
AL MK SMS PK EP BD PLM FLM.
References
1. Fahey MT, Irwig L, Macaskill P (1995) Meta-analysis of Pap test accuracy.
Am J Epidemiol 141: 680–689.
2. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, et al. (2000)
Accuracy of the Papanicolaou test in screening for and follow-up of cervical
cytologic abnormalities: a systematic review. Ann Intern Med 132: 810–819.
3. McCrory DC, Matchar DB, Bastian L, Datta S, Hasselblad V, et al. (1999)
Evaluation of cervical cytology. Evid Rep Technol Assess (Summ) 5: 1–6.
4. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, et al. (2006) Overview of the
European and North American studies on HPV testing in primary cervical
cancer screening. Int J Cancer 119: 1095–1101.
5. Baldwin P, Laskey R, Coleman N (2003) Translational approaches to improving
cervical screening. Nat Rev Cancer 3: 217–226.
6. Castanon A, Ferryman S, Patnick J, Sasieni P (2012) Review of cytology and
histopathology as part of the NHS Cervical Screening Programme audit of
invasive cervical cancers. Cytopathology 23: 13–22.
7. Kelly JG, Trevisan J, Scott AD, Carmichael PL, Pollock HM, et al. (2011)
Biospectroscopy to metabolically profile biomolecular structure: a multistage
approach linking computational analysis with biomarkers. J Proteome Res 10:
1437–1448.
8. Martin FL, Kelly JG, Llabjani V, Martin-Hirsch PL, Patel II, et al. (2010)
Distinguishing cell types or populations based on the computational analysis of
their infrared spectra. Nat Protoc 5: 1748–1760.
9. Walsh MJ, Singh MN, Pollock HM, Cooper LJ, German MJ, et al. (2007) ATR
microspectroscopy with multivariate analysis segregates grades of exfoliative
cervical cytology. Biochem Biophys Res Commun 352: 213–219.
10. Gajjar K, Heppenstall LD, Pang W, Ashton KM, Trevisan J, et al. (2013)
Diagnostic segregation of human brain tumours using Fourier-transform
infrared and/or Raman spectroscopy coupled with discriminant analysis. Anal
Methods 5: 89–102.
11. Wood BR, Chiriboga L, Yee H, Quinn MA, McNaughton D, et al. (2004)
Fourier transform infrared (FTIR) spectral mapping of the cervical transforma-
tion zone, and dysplastic squamous epithelium. Gynecol Oncol 93: 59–68.
12. Taylor SE, Cheung KT, Patel, II, Trevisan J, Stringfellow HF, et al. (2011)
Infrared spectroscopy with multivariate analysis to interrogate endometrial
tissue: a novel and objective diagnostic approach. Br J Cancer 104: 790–797.
13. Wachsmann-Hogiu S, Weeks T, Huser T (2009) Chemical analysis in vivo and
in vitro by Raman spectroscopy–from single cells to humans. Curr Opin
Biotechnol 20: 63–73.
14. Mahadevan-Jansen A, Mitchell MF, Ramanujam N, Malpica A, Thomsen S,
et al. (1998) Near-infrared Raman spectroscopy for in vitro detection of cervical
precancers. Photochem Photobiol 68: 123–132.
15. Mahadevan-Jansen A, Mitchell MF, Ramanujam N, Utzinger U, Richards-
Kortum R (1998) Development of a fiber optic probe to measure NIR Raman
spectra of cervical tissue in vivo. Photochem Photobiol 68: 427–431.
16. Kanter EM, Vargis E, Majumder S, Keller MD, Woeste E, et al. (2009)
Application of Raman spectroscopy for cervical dysplasia diagnosis.
J Biophotonics 2: 81–90.
17. Duraipandian S, Zheng W, Ng J, Low JJ, Ilancheran A, et al. (2013) Near-
infrared-excited confocal Raman spectroscopy advances in vivo diagnosis of
cervical precancer. J Biomed Opt 18: 067007.
18. Kelly JG, Angelov PP, Trevisan J, Vlachopoulou A, Paraskevaidis E, et al. (2010)
Robust classification of low-grade cervical cytology following analysis with ATR-
FTIR spectroscopy and subsequent application of self-learning classifier eClass.
Anal Bioanal Chem 398: 2191–2201.
19. Walsh MJ, Singh MN, Stringfellow HF, Pollock HM, Hammiche A, et al. (2008)
FTIR microspectroscopy coupled with two-class discrimination segregates
markers responsible for inter- and intra-category variance in exfoliative cervical
cytology. Biomark Insights 3: 179–189.
20. Yazdi HM, Bertrand MA, Wong PT (1996) Detecting structural changes at the
molecular level with Fourier transform infrared spectroscopy. A potential tool for
prescreening preinvasive lesions of the cervix. Acta Cytol 40: 664–668.
21. Wong PT, Wong RK, Caputo TA, Godwin TA, Rigas B (1991) Infrared
spectroscopy of exfoliated human cervical cells: evidence of extensive structural
changes during carcinogenesis. Proc Natl Acad Sci USA 88: 10988–10992.
22. Sindhuphak R, Issaravanich S, Udomprasertgul V, Srisookho P, Warakamin S,
et al. (2003) A new approach for the detection of cervical cancer in Thai women.
Gynecol Oncol 90: 10–14.
23. Purandare NC, Trevisan J, Patel II, Gajjar K, Mitchell A, et al. (2013)
Exploiting biospectroscopy as a novel diagnostic tool for cervical cancer: towards
a framework to validate its accuracy in a routine clinical setting. Bioanalysis 5:
2697–2711.
24. Kelly JG, Cheung KT, Martin C, O’Leary JJ, Prendiville W, et al. (2010) A
spectral phenotype of oncogenic human papillomavirus-infected exfoliative
cervical cytology distinguishes women based on age. Clin Chim Acta 411: 1027–
1033.
25. Wright TC, Jr., Kuhn L (2012) Alternative approaches to cervical cancer
screening for developing countries. Best Pract Res Clin Obstet Gynaecol 26:
197–208.
26. Wood BR, Quinn MA, Tait B, Ashdown M, Hislop T, et al. (1998) FTIR
microspectroscopic study of cell types and potential confounding variables in
screening for cervical malignancies. Biospectroscopy 4: 75–91.
27. Chiriboga L, Xie P, Vigorita V, Zarou D, Zakim D, et al. (1998) Infrared
spectroscopy of human tissue. II. A comparative study of spectra of biopsies of
cervical squamous epithelium and of exfoliated cervical cells. Biospectroscopy 4:
55–59.
28. Wong PT, Senterman MK, Jackli P, Wong RK, Salib S, et al. (2002) Detailed
account of confounding factors in interpretation of FTIR spectra of exfoliated
cervical cells. Biopolymers 67: 376–386.
29. Purandare NC, Patel II, Trevisan J, Bolger N, Kelehan R, et al. (2013)
Biospectroscopy insights into the multi-stage process of cervical cancer
development: probing for spectral biomarkers in cytology to distinguish grades.
Analyst 138: 3909–3916.
30. El-Tawil SG, Adnan R, Muhamed ZN, Othman NH (2008) Comparative study
between Pap smear cytology and FTIR spectroscopy: a new tool for screening
for cervical cancer. Pathology 40: 600–603.
31. Njoroge E, Alty SR, Gani MR, Alkatib M (2006) Classification of cervical cancer
cells using FTIR data. Conf Proc IEEE Eng Med Biol Soc 1: 5338–5341.
32. Apgar BS, Zoschnick L, Wright TC, Jr. (2003) The 2001 Bethesda System
terminology. Am Fam Physician 68: 1992–1998.
33. Trevisan J, Angelov PP, Scott AD, Carmichael PL, Martin FL (2013) IRootLab:
a free and open-source MATLAB toolbox for vibrational biospectroscopy data
analysis. Bioinformatics 29: 1095–1097.
34. Mohlenhoff B, Romeo M, Diem M, Wood BR (2005) Mie-type scattering and
non-Beer-Lambert absorption behavior of human cells in infrared microspec-
troscopy. Biophys J 88: 3635–3640.
35. Trevisan J, Angelov PP, Carmichael PL, Scott AD, Martin FL (2012) Extracting
biological information with computational analysis of Fourier-transform infrared
(FTIR) biospectroscopy datasets: current practices to future perspectives. Analyst
137: 3202–3215.
36. Gajjar K, Trevisan J, Owens G, Keating PJ, Wood NJ, et al. (2013) Fourier-
transform infrared spectroscopy coupled with a classification machine for the
Biospectroscopy of Liquid-Based Cervical Cytology
PLOS ONE | www.plosone.org 15 January 2014 | Volume 9 | Issue 1 | e82416
analysis of blood plasma or serum: a novel diagnostic approach for ovarian
cancer. Analyst 138: 3917–3926.
37. Baker MJ, Gazi E, Brown MD, Shanks JH, Gardner P, et al. (2008) FTIR-based
spectroscopic analysis in the identification of clinically aggressive prostate cancer.
Br J Cancer 99: 1859–1866.
38. Martin FL, German MJ, Wit E, Fearn T, Ragavan N, et al. (2007) Identifying
variables responsible for clustering in discriminant analysis of data from infrared
microspectroscopy of a biological sample. J Comput Biol 14: 1176–1184.
39. Llabjani V, Trevisan J, Jones KC, Shore RF, Martin FL (2010) Binary mixture
effects by PBDE congeners (47, 153, 183, or 209) and PCB congeners (126 or
153) in MCF-7 cells: biochemical alterations assessed by IR spectroscopy and
multivariate analysis. Environ Sci Technol 44: 3992–3998.
40. Llabjani V, Jones KC, Thomas GO, Walker LA, Shore RF, et al. (2009)
Polybrominated diphenyl ether-associated alterations in cell biochemistry as
determined by attenuated total reflection Fourier-transform infrared spectros-
copy: a comparison with DNA-reactive and/or endocrine-disrupting agents.
Environ Sci Technol 43: 3356–3364.
41. Dunn OJ (1964) Multiple Comparisons Using Rank Sums. Technometrics 6:
241–252.
42. Daniel WW (1990) Applied Nonparametric Statistics. Boston: PWS-Kent
publishers.
43. Ismail SM, Colclough AB, Dinnen JS, Eakins D, Evans DM, et al. (1989)
Observer variation in histopathological diagnosis and grading of cervical
intraepithelial neoplasia. BMJ 298: 707–710.
44. Price GJ, McCluggage WG, Morrison MM, McClean G, Venkatraman L, et al.
(2003) Computerized diagnostic decision support system for the classification of
preinvasive cervical squamous lesions. Hum Pathol 34: 1193–1203.
45. Mitchell MF, Tortolero-Luna G, Wright T, Sarkar A, Richards-Kortum R, et al.
(1996) Cervical human papillomavirus infection and intraepithelial neoplasia: a
review. J Natl Cancer Inst Monogr (21): 17–25.
46. Castle PE, Stoler MH, Wright TC, Jr., Sharma A, Wright TL, et al. (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16
or HPV18 genotyping for cervical cancer screening of women aged 25 years and
older: a subanalysis of the ATHENA study. Lancet Oncol 12: 880–890.
47. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, et al,
Canadian Cervical Cancer Screening Trial Study Group (2007) Human
papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
N Engl J Med 357: 1579–1588.
48. Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, et al. (2009)
HPV testing in combination with liquid-based cytology in primary cervical
screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 10: 672–
682.
49. Sauvaget C, Fayette JM, Muwonge R, Wesley R, Sankaranarayanan R, et al.
(2011) Accuracy of visual inspection with acetic acid for cervical cancer
screening. Int J Gynaecol Obstet 113: 14–24.
50. Stoler MH, Schiffman M, Atypical Squamous Cells of Undetermined
Significance-Low-grade Squamous Intraepithelial Lesion Triage Study Group
(2001) Interobserver reproducibility of cervical cytologic and histologic
interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA
285: 1500–1505.
51. Kyrgiou M, Arbyn M, Martin-Hirsch P, Paraskevaidis E (2012) Increased risk of
preterm birth after treatment for CIN. BMJ 345: e5847.
52. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, et al. (2008)
Perinatal mortality and other severe adverse pregnancy outcomes associated
with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 337:
a1284.
53. Paraskevaidis E, Kyrgiou M, Martin-Hirsch P (2007) Have we dismissed ablative
treatment too soon in colposcopy practice? BJOG 114: 3–4.
54. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W,
et al.(2006) Obstetric outcomes after conservative treatment for intraepithelial or
early invasive cervical lesions: systematic review and meta-analysis. Lancet 367:
489–498.
Biospectroscopy of Liquid-Based Cervical Cytology
PLOS ONE | www.plosone.org 16 January 2014 | Volume 9 | Issue 1 | e82416
